RHYTHM PHARMACEUTICALS, INC. Deferred Income Tax Liabilities, Net
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Deferred Income Tax Liabilities, Net of $7.99 million as of 2021-09-30, per its 10-Q filed 2021-11-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2021-11-02
- 2021-09-30: Deferred Income Tax Liabilities, Net $7.99M.
- 2021-06-30: Deferred Income Tax Liabilities, Net $16.98M.
- 2021-03-31: Deferred Income Tax Liabilities, Net $22.01M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2021-09-30 | $7.99M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $16.98M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $22.01M 10-Q · filed 2021-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |